Mauricio de la Fuente-Lira
Mexican Social Security Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mauricio de la Fuente-Lira.
Cirugia Y Cirujanos | 2017
Luis Manuel Souza-Gallardo; Mauricio de la Fuente-Lira; Roberto Galaso-Trujillo; José Luis Martínez-Ordaz
BACKGROUND Tumour markers are substances produced by the tumour itself, or by the host in response to a tumour. These markers could be measured either in the blood or in body secretions. One of the most common tumour markers used in gastrointestinal diseases is Ca 19-9. It is the marker most used for pancreatic cancer, but can be elevated in many benign processes. Thus, it is not a specific marker. CLINICAL CASE The case is presented of a male patient with 4 years of moderate abdominal pain, weight loss, and persistent elevation of Ca 19-9. After an extensive work-up, renal and hepatic cysts were found, as well as steatosis and, apparently, a gallbladder polyp. With these findings and the persistent elevation of Ca 19-9, it was decided to operate the patient. An exploratory laparoscopy was performed showing multiple, yellowish nodular lesions all over the hepatic surface suggestive of metastases, as well as simple hepatic cysts. Pathology reported biliary hamartomas, steatosis, and chronic cholecystitis. After 2years of follow up, although there is no evidence of malignant neoplasia, there is still an elevation of Ca 19-9. CONCLUSION The persistent elevation of Ca 19-9 is probably due to the presence of multiple benign diseases such as steatosis, urolithiasis, hepatic and renal cysts, and cholecystitis. An algorithm is needed for healthy patients with elevated levels of Ca 19-9 marker, in order to lower costs, avoid misdiagnoses, and improve management.
Cirugia Y Cirujanos | 2017
Larry Romero-Espinosa; Luis Manuel Souza-Gallardo; José Luis Martínez-Ordaz; Teodoro Romero-Hernández; Mauricio de la Fuente-Lira; Jorge Arellano-Sotelo
BACKGROUND The gastrointestinal stromal tumours (GIST) are the most common soft tissue sarcomas of the digestive tract. They are usually found in the stomach (60-70%) and small intestine (25-30%) and, less commonly, in the oesophagus, mesentery, colon, or rectum. The symptoms present at diagnosis are, gastrointestinal bleeding, abdominal pain, abdominal mass, or intestinal obstruction. The type of symptomatology will depend on the location and size of the tumour. The definitive diagnosis is histopathological, with 95% of the tumours being positive for CD117. CLINICAL CASES This is an observational and descriptive study of 5cases of small intestinal GIST that presented with gastrointestinal bleeding as the main symptom. The period from the initial symptom to the diagnosis varied from 1 to 84 months. The endoscopy was inconclusive in all of the patients, and the diagnosis was made using computed tomography and angiography. Treatment included resection in all patients. The histopathological results are also described. CONCLUSION GIST can have multiple clinical pictures and unusual symptoms, such as obscure gastrointestinal bleeding. The use of computed tomography and angiography has shown to be an important tool in the diagnosis with patients with small intestine GISTs.
Cirugia Y Cirujanos | 2016
José Luis Martínez-Ordaz; Magdely Yazmin Morales-Camacho; Sócrates Centellas-Hinojosa; Eduardo Román-Ramírez; Teodoro Romero-Hernández; Mauricio de la Fuente-Lira
BACKGROUND Choledochal cysts are rare. They usually present during childhood in women, but it can also be seen during pregnancy. Clinical signs and symptoms are obscured during this time, thus it can complicate the diagnosis and represent a life threatening complication for both the mother and the child. OBJECTIVE To communicate the case of 3 pregnant patients with choledochal cyst. CLINICAL CASES Three pregnant women in which choledochal cyst were diagnosed. Two developed signs of cholangitis. The first one underwent a hepatic-jejunostomy, but had an abortion and died on postoperative day 10. The second one had a preterm caesarean operation due to foetal distress and underwent a hepatic-jejunostomy 4 weeks later; during her recovery she had a gastric perforation and died of septic complications. The third one did not develop cholangitis or jaundice. She had an uneventful pregnancy and had a hepatic-jejunostomy 4 weeks later with good results. CONCLUSIONS Management of choledochal cysts during pregnancy is related to the presence of cholangitis. When they do not respond to medical treatment, decompression of the biliary tree is indicated. Definitive treatment should be performed after resolution of the pregnancy.
Cirugia Y Cirujanos | 2002
Mauricio de la Fuente-Lira; Víctor Hugo Mendoza M; Felipe Robledo-Ogazón; Juan Mier y Díaz; José Luis Martínez-Ordaz; Roberto Blanco-Benavides
Cirugia Y Cirujanos | 2006
Mauricio de la Fuente-Lira; Cuauhtémoc Molotla-Xolalpa; Erick Rolando Rocha-Guevara
Cirugia Y Cirujanos | 2006
Carlos Salazar-Lozano; Erick Rolando Rocha-Guevara; Alberto Vargas-Gismondi; Mauricio de la Fuente-Lira; Rodrigo Ernesto de Obaldía-Zeledón; Carlos Cordero-Vargas
Revista Portuguesa De Pneumologia | 2004
José Luis Martínez-Ordaz; Pedro Armando Cruz-Olivo; Ericka Chacón-Moya; Mauricio de la Fuente-Lira; Manuel Chavelas-Lluck; Roberto Blanco-Benavides
Cirugia Y Cirujanos | 2005
Gaby Adriana Alarcón-Jarsún; José Luis Martínez-Ordaz; Mauricio de la Fuente-Lira; Roberto Blanco-Benavides
Cirugia Y Cirujanos | 2003
Mauricio de la Fuente-Lira; Gilberto Cornejo-López; José Luis Martínez-Ordaz; Guillermo Becerril-Martínez; Teodoro Romero-Hernández
Cirugia Y Cirujanos | 2016
José Luis Martínez-Ordaz; Magdely Yazmin Morales-Camacho; Sócrates Centellas-Hinojosa; Eduardo Román-Ramírez; Teodoro Romero-Hernández; Mauricio de la Fuente-Lira